Treatment Outcome of Cisplatin-based Concurrent Chemoradiotherapy in the Patients with Locally Advanced Nasopharyngeal Cancer

PURPOSE: The standard treatment of locally advanced nasopharyngeal cancer is a concurrent chemoradiotherapy (CCRT), and cisplatin has been used as the most popular chemotherapeutic agent. But many different doses and schedules for cisplatin administration such as daily, weekly and 3 week cycles have...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Tae Hee, Ko, Yoon Ho, Lee, Myung Ah, Kim, Bum-soo, Chung, So Ryoung, Yoo, Ie Ryung, Jung, Chan-Kwon, Kim, Yeon-Sil, Kim, Min Sik, Sun, Dong-Il, Hong, Young Seon, Lee, Kyung Shik, Kang, Jin-Hyoung
Format: Artigo
Idioma:Inglês
Publicat: Korean Cancer Association 2008
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697486/
https://ncbi.nlm.nih.gov/pubmed/19688050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2008.40.2.62
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars